The risk or severity of adverse effects can be increased when chlormezanone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with alclofenac.


The risk or severity of adverse effects can be increased when butabarbital is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when butalbital is combined with Difenoxin.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Mometasone.


The risk or severity of adverse effects can be increased when tolnaftate is combined with gabapentin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with dicumarol.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when meprobamate is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Bazedoxifene is combined with Ospemifene.


The risk or severity of adverse effects can be increased when meprobamate is combined with clemastine.


The risk or severity of adverse effects can be increased when tolazoline is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with loteprednol.


The risk or severity of adverse effects can be increased when protriptyline is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when trandolapril is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Tramadol is combined with Asenapine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when procarbazine is combined with quetiapine.


The risk or severity of adverse effects can be increased when trazodone is combined with zotepine.


The risk or severity of adverse effects can be increased when trazodone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when butorphanol is combined with potassium ion.


The risk or severity of adverse effects can be increased when ondansetron is combined with Normethadone.


The risk or severity of adverse effects can be increased when Etidocaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with tizanidine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with betaxolol.


The risk or severity of adverse effects can be increased when quazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with furosemide.


The risk or severity of adverse effects can be increased when Salsalate is combined with Apremilast.


The risk or severity of adverse effects can be increased when tetracaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when epoprostenol is combined with tizanidine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with furosemide.


The risk or severity of adverse effects can be increased when topotecan is combined with atorvastatin.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with sotalol.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Nabilone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with brimonidine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when methyldopa is combined with hydralazine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Butethal.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with hydralazine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when sulfamethizole is combined with mecamylamine.


The risk or severity of adverse effects can be increased when linezolid is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when linezolid is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when resveratrol is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with scopolamine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when meperidine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Riociguat.


The risk or severity of adverse effects can be increased when resveratrol is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when halcinonide is combined with mefloquine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with methazolamide.


The risk or severity of adverse effects can be increased when ibuprofen is combined with salicylamide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when enalapril is combined with Metipranolol.


The risk or severity of adverse effects can be increased when trimetrexate is combined with Pinaverium.


The risk or severity of adverse effects can be increased when Eprosartan is combined with epirizole.


The risk or severity of adverse effects can be increased when enalapril is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when meperidine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when butabarbital is combined with paroxetine.


The risk or severity of adverse effects can be increased when selegiline is combined with periciazine.


The risk or severity of adverse effects can be increased when brimonidine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when barnidipine is combined with Riociguat.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with prilocaine.


The risk or severity of adverse effects can be increased when loxapine is combined with phenobarbital.


The risk or severity of adverse effects can be increased when Olsalazine is combined with estrone.


The risk or severity of adverse effects can be increased when meprobamate is combined with halothane.


The risk or severity of adverse effects can be increased when Limaprost is combined with ACENOCOUMAROL.


The risk or severity of adverse effects can be increased when meprobamate is combined with thiamylal.


The risk or severity of adverse effects can be increased when meprobamate is combined with desipramine.


The risk or severity of adverse effects can be increased when Vecuronium is combined with HEROIN.


The risk or severity of adverse effects can be increased when ketoprofen is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Carbetocin is combined with metolazone.


The risk or severity of adverse effects can be increased when Carbetocin is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when bepridil is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when clomipramine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when bumetanide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with flunisolide.


The risk or severity of adverse effects can be increased when orphenadrine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when chlormezanone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when chlormezanone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Tiotropium is combined with oxycodone.


The risk or severity of adverse effects can be increased when nortriptyline is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when thalidomide is combined with tretinoin.


The risk or severity of adverse effects can be increased when tiapride is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when Fospropofol is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with fenbufen.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Apremilast is combined with fluocinonide.


The risk or severity of adverse effects can be increased when imipramine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when topiramate is combined with Olopatadine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Masoprocol is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Agomelatine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when salicylic acid is combined with budesonide.


The risk or severity of adverse effects can be increased when Melatonin is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Melatonin is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when temazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when ethotoin is combined with maprotiline.


The risk or severity of adverse effects can be increased when benazepril is combined with tolmetin.


The risk or severity of adverse effects can be increased when Ticagrelor is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when nisoldipine is combined with methyldopa.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Ditazole.


The risk or severity of adverse effects can be increased when Crizotinib is combined with Flibanserin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with thiothixene.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when scopolamine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with chlormezanone.


The risk or severity of adverse effects can be increased when nimodipine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when lorazepam is combined with thioridazine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with anastrozole.


The risk or severity of adverse effects can be increased when Paliperidone is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Flupentixol is combined with phenobarbital.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when nimodipine is combined with methyldopa.


The risk or severity of adverse effects can be increased when bromocriptine is combined with doxazosin.


The risk or severity of adverse effects can be increased when Asenapine is combined with Halazepam.


The risk or severity of adverse effects can be increased when bromocriptine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Asenapine is combined with proparacaine.


The risk or severity of adverse effects can be increased when Melatonin is combined with baclofen.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with indapamide.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Naloxegol.


The risk or severity of adverse effects can be increased when rizatriptan is combined with periciazine.


The risk or severity of adverse effects can be increased when butalbital is combined with scopolamine.


The risk or severity of adverse effects can be increased when baclofen is combined with nefazodone.


The risk or severity of adverse effects can be increased when 3,4-Dihydroxybenzaldehyde is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when olanzapine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when salicylamide is combined with diflorasone.


The risk or severity of adverse effects can be increased when olanzapine is combined with triprolidine.


The risk or severity of adverse effects can be increased when minoxidil is combined with benazepril.


The risk or severity of adverse effects can be increased when Telmisartan is combined with epirizole.


The risk or severity of adverse effects can be increased when halothane is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when gabapentin is combined with MELPERONE.


The risk or severity of adverse effects can be increased when gabapentin is combined with zotepine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when Carbetocin is combined with cilazapril.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with dantrolene.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with dipyridamole.


The risk or severity of adverse effects can be increased when fludiazepam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with protriptyline.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Glubionate calcium is combined with dihydrotachysterol.


The risk or severity of adverse effects can be increased when Tramadol is combined with tiapride.


The risk or severity of adverse effects can be increased when lorazepam is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with acemetacin.


The risk or severity of adverse effects can be increased when zotepine is combined with cetirizine.


The risk or severity of adverse effects can be increased when zotepine is combined with protriptyline.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with losartan.


The risk or severity of adverse effects can be increased when loratadine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when indapamide is combined with acebutolol.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when clenbuterol is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with desipramine.


The risk or severity of adverse effects can be increased when methysergide is combined with anastrozole.


The risk or severity of adverse effects can be increased when reserpine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when Flibanserin is combined with paroxetine.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Clevidipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when primidone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with ethotoin.


The risk or severity of adverse effects can be increased when Flupentixol is combined with enflurane.


The risk or severity of adverse effects can be increased when quinapril is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when quinapril is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with furosemide.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with valsartan.


The risk or severity of adverse effects can be increased when amphotericin b is combined with enalapril.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with baclofen.


The risk or severity of adverse effects can be increased when Articaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with brotizolam.


The risk or severity of adverse effects can be increased when Cyamemazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Masoprocol is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with tiagabine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with periciazine.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when scopolamine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when tiapride is combined with primidone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with histamine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with SIMEPREVIR.


The risk or severity of adverse effects can be increased when methylergonovine is combined with testosterone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with efavirenz.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with cocaine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with nicardipine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vilanterol.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when ACETOPHENAZINE is combined with methylphenidate.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with phenytoin.


The risk or severity of adverse effects can be increased when amifostine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when diflunisal is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Icatibant is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Arotinolol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when dicyclomine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when fluocinonide is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with mirtazapine.


The risk or severity of adverse effects can be increased when secobarbital is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with pimozide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Riociguat.


The risk or severity of adverse effects can be increased when isoflurane is combined with Articaine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with acebutolol.


The risk or severity of adverse effects can be increased when cocaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Perospirone.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when benztropine is combined with Metixene.


The risk or severity of adverse effects can be increased when methylergonovine is combined with doxorubicin.


The risk or severity of adverse effects can be increased when methysergide is combined with raloxifene.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when lorazepam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when griseofulvin is combined with nicardipine.


The risk or severity of adverse effects can be increased when metolazone is combined with losartan.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with ritodrine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when ILOPROST is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when leflunomide is combined with halcinonide.


The risk or severity of adverse effects can be increased when leflunomide is combined with difluprednate.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Clobetasone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when lisinopril is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when Clobetasone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when thioridazine is combined with Melatonin.


The risk or severity of adverse effects can be increased when levodopa is combined with methylene blue.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when pimozide is combined with Paliperidone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when ketoconazole is combined with toremifene.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when betaxolol is combined with bumetanide.


The risk or severity of adverse effects can be increased when Isoflurophate is combined with Varenicline.


The risk or severity of adverse effects can be increased when glutethimide is combined with clomipramine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with benzocaine.


The risk or severity of adverse effects can be increased when equilin is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when halothane is combined with Milnacipran.


The risk or severity of adverse effects can be increased when lisinopril is combined with antipyrine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when cabergoline is combined with protriptyline.


The risk or severity of adverse effects can be increased when isoflurane is combined with Agomelatine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Eplerenone is combined with Aliskiren.


The risk or severity of adverse effects can be increased when DESONIDE is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Paliperidone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when proparacaine is combined with levodopa.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with Indacaterol.


The risk or severity of adverse effects can be increased when DESONIDE is combined with malathion.


The risk or severity of adverse effects can be increased when proparacaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when morphine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when trazodone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with pramipexole.


The risk or severity of adverse effects can be increased when morphine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when imipramine is combined with spironolactone.


The risk or severity of adverse effects can be increased when morphine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when morphine is combined with methazolamide.


The risk or severity of adverse effects can be increased when prednisone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with irbesartan.


The risk or severity of adverse effects can be increased when Vilazodone is combined with maprotiline.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with rivastigmine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with felodipine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with proparacaine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with carvedilol.


The risk or severity of adverse effects can be increased when proparacaine is combined with imipramine.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with physostigmine.


The risk or severity of adverse effects can be increased when flurazepam is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when Icatibant is combined with desoximetasone.


The risk or severity of adverse effects can be increased when enalapril is combined with chloroquine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when nimodipine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when enalapril is combined with sulindac.


The risk or severity of adverse effects can be increased when tiapride is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when triprolidine is combined with maprotiline.


The risk or severity of adverse effects can be increased when prazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when pentazocine is combined with cetirizine.


The risk or severity of adverse effects can be increased when ondansetron is combined with levodopa.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Etidocaine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when ondansetron is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Pentolinium is combined with levorphanol.


The risk or severity of adverse effects can be increased when amoxapine is combined with desipramine.


The risk or severity of adverse effects can be increased when methscopolamine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when trimipramine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Conivaptan.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when triazolam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when methadone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when fluocinonide is combined with enoxacin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with loratadine.


The risk or severity of adverse effects can be increased when Isoconazole is combined with felodipine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when oxaprozin is combined with resveratrol.


The risk or severity of adverse effects can be increased when Olsalazine is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when losartan is combined with epirizole.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with nimesulide.


The risk or severity of adverse effects can be increased when clonidine is combined with efavirenz.


The risk or severity of adverse effects can be increased when clonidine is combined with nicardipine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when formestane is combined with Deferasirox.


The risk or severity of adverse effects can be increased when METYROSINE is combined with Tianeptine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with levodopa.


The risk or severity of adverse effects can be increased when butorphanol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when trazodone is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Mometasone is combined with ambenonium.


The risk or severity of adverse effects can be increased when HEROIN is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when carprofen is combined with halcinonide.


The risk or severity of adverse effects can be increased when Talniflumate is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when Talniflumate is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Almotriptan is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Almotriptan is combined with zotepine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with fosinopril.


The risk or severity of adverse effects can be increased when griseofulvin is combined with nilvadipine.


The risk or severity of adverse effects can be increased when acemetacin is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Etomidate is combined with ondansetron.


The risk or severity of adverse effects can be increased when Etomidate is combined with tiagabine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with promethazine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with clonazepam.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when metoprolol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when MELPERONE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when desoximetasone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when equilin is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when propantheline is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when propofol is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Salsalate is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when quetiapine is combined with bromazepam.


The risk or severity of adverse effects can be increased when zaleplon is combined with Fospropofol.


The risk or severity of adverse effects can be increased when terbinafine is combined with Pinaverium.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when propofol is combined with selegiline.


The risk or severity of adverse effects can be increased when cilnidipine is combined with isoflurane.


The risk or severity of adverse effects can be increased when cilnidipine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with tretinoin.


The risk or severity of adverse effects can be increased when methadone is combined with buspirone.


The risk or severity of adverse effects can be increased when Riociguat is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with mecamylamine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Droxicam is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Pramocaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when diclofenac is combined with triamcinolone.


The risk or severity of adverse effects can be increased when bepridil is combined with halothane.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when zaleplon is combined with paroxetine.


The risk or severity of adverse effects can be increased when isoflurane is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when isoflurane is combined with benazepril.


The risk or severity of adverse effects can be increased when morniflumate is combined with Icatibant.


The risk or severity of adverse effects can be increased when Perospirone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Apremilast.


The risk or severity of adverse effects can be increased when sulpiride is combined with clonazepam.


The risk or severity of adverse effects can be increased when tropicamide is combined with hydromorphone.


The risk or severity of adverse effects can be increased when floctafenine is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Nabilone is combined with ramipril.


The risk or severity of adverse effects can be increased when dibucaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ribavirin is combined with didanosine.


The risk or severity of adverse effects can be increased when floctafenine is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Nabilone is combined with valsartan.


The risk or severity of adverse effects can be increased when risperidone is combined with gabapentin.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with paramethasone.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with HEROIN.


The risk or severity of adverse effects can be increased when celecoxib is combined with fenbufen.


The risk or severity of adverse effects can be increased when epirizole is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when equilin is combined with physostigmine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with clonazepam.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with promethazine.


The risk or severity of adverse effects can be increased when diclofenac is combined with oxaprozin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with risperidone.


The risk or severity of adverse effects can be increased when Limaprost is combined with Cangrelor.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Agomelatine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Isoconazole is combined with simvastatin.


The risk or severity of adverse effects can be increased when protriptyline is combined with zonisamide.


The risk or severity of adverse effects can be increased when Atazanavir is combined with indinavir.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with streptozocin.


The risk or severity of adverse effects can be increased when pentazocine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when galanthamine is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when protriptyline is combined with tiagabine.


The risk or severity of adverse effects can be increased when secobarbital is combined with zonisamide.


The risk or severity of adverse effects can be increased when pentazocine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when nystatin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when chloroquine is combined with Halobetasol.


The risk or severity of adverse effects can be increased when chloroquine is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with risperidone.


The risk or severity of adverse effects can be increased when nystatin is combined with xylometazoline.


The risk or severity of adverse effects can be increased when alprazolam is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with ceritinib.


The risk or severity of adverse effects can be increased when dyclonine is combined with dantrolene.


The risk or severity of adverse effects can be increased when methoxamine is combined with ritodrine.


The risk or severity of adverse effects can be increased when methoxamine is combined with benzphetamine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with butalbital.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when metoprolol is combined with minoxidil.


The risk or severity of adverse effects can be increased when norepinephrine is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when haloprogin is combined with nifedipine.


The risk or severity of adverse effects can be increased when bromazepam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when methysergide is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when bromazepam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when phenobarbital is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when propoxyphene is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when clorazepate is combined with enflurane.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with etoposide.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when pentazocine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when fosinopril is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when papaverine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when pentazocine is combined with flurazepam.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Olopatadine.


The risk or severity of adverse effects can be increased when fosinopril is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when imipramine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when fosinopril is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Torasemide is combined with dipyridamole.


The risk or severity of adverse effects can be increased when buspirone is combined with lithium ion.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with prazepam.


The risk or severity of adverse effects can be increased when tizanidine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with loxapine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with amoxapine.


The risk or severity of adverse effects can be increased when Nabilone is combined with diltiazem.


The risk or severity of adverse effects can be increased when protriptyline is combined with clenbuterol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with amitriptyline.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Tolcapone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Arformoterol.


The risk or severity of adverse effects can be increased when nimesulide is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when carbamazepine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with oxycodone.


The risk or severity of adverse effects can be increased when zotepine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when clorazepate is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Conivaptan is combined with fosinopril.


The risk or severity of adverse effects can be increased when sevoflurane is combined with tolazoline.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with nefazodone.


The risk or severity of adverse effects can be increased when valsartan is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when citalopram is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Perospirone is combined with maprotiline.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with mefloquine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with doxepin.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when triprolidine is combined with amoxapine.


The risk or severity of adverse effects can be increased when amoxapine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when meprobamate is combined with etizolam.


The risk or severity of adverse effects can be increased when triprolidine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Rufinamide is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with levorphanol.


The risk or severity of adverse effects can be increased when flurazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Halazepam.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with prednisone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when sulindac is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Agomelatine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when methadone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Tixocortol is combined with malathion.


The risk or severity of adverse effects can be increased when nicergoline is combined with dexamethasone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with fosinopril.


The risk or severity of adverse effects can be increased when Halazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Etomidate.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when indapamide is combined with captopril.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Ramelteon.


The risk or severity of adverse effects can be increased when sevoflurane is combined with diflunisal.


The risk or severity of adverse effects can be increased when Asenapine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when clenbuterol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Isavuconazonium is combined with oxycodone.


The risk or severity of adverse effects can be increased when galanthamine is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when clozapine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Pregabalin.


The risk or severity of adverse effects can be increased when clozapine is combined with tolazoline.


The risk or severity of adverse effects can be increased when clozapine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when etizolam is combined with triprolidine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when pergolide is combined with azithromycin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with phentolamine.


The risk or severity of adverse effects can be increased when etizolam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when isoxsuprine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when selegiline is combined with thalidomide.


The risk or severity of adverse effects can be increased when nicergoline is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when amoxapine is combined with celiprolol.


The risk or severity of adverse effects can be increased when amoxapine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with pargyline.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when midazolam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when desipramine is combined with Salmeterol.


The risk or severity of adverse effects can be increased when trandolapril is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when codeine is combined with butamben.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with cinoxacin.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with clonidine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when trandolapril is combined with Salsalate.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Pipamperone.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when cilazapril is combined with epirizole.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Icatibant.


The risk or severity of adverse effects can be increased when enflurane is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when spironolactone is combined with Eprosartan.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with tiapride.


The risk or severity of adverse effects can be increased when ramipril is combined with furosemide.


The risk or severity of adverse effects can be increased when ramipril is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Eprosartan is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when bumetanide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when bumetanide is combined with felodipine.


The risk or severity of adverse effects can be increased when biperiden is combined with pentazocine.


The risk or severity of adverse effects can be increased when biperiden is combined with mecamylamine.


The risk or severity of adverse effects can be increased when bumetanide is combined with irbesartan.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when clozapine is combined with benazepril.


The risk or severity of adverse effects can be increased when ipratropium is combined with Mirabegron.


The risk or severity of adverse effects can be increased when nicergoline is combined with Bortezomib.


The risk or severity of adverse effects can be increased when dantrolene is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ILOPROST is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Tramadol is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when isoflurane is combined with oxazepam.


The risk or severity of adverse effects can be increased when triazolam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when gabapentin is combined with fexofenadine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with dyclonine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with reserpine.


The risk or severity of adverse effects can be increased when reserpine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when isoflurane is combined with nalbuphine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with medrysone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Normethadone.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Agomelatine is combined with tiapride.


The risk or severity of adverse effects can be increased when pilocarpine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with malathion.


The risk or severity of adverse effects can be increased when Olopatadine is combined with DESONIDE.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with quetiapine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with felodipine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when flunisolide is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when ketoprofen is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when thioridazine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with celecoxib.


The risk or severity of adverse effects can be increased when Icatibant is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Iloperidone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when formestane is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with trandolapril.


The risk or severity of adverse effects can be increased when epoprostenol is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with salicylamide.


The risk or severity of adverse effects can be increased when rescinnamine is combined with ketoprofen.


The risk or severity of adverse effects can be increased when fenbufen is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Perospirone is combined with tiapride.


The risk or severity of adverse effects can be increased when etodolac is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when tizanidine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Phenelzine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when nalbuphine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when halothane is combined with vigabatrin.


The risk or severity of adverse effects can be increased when selegiline is combined with terbutaline.


The risk or severity of adverse effects can be increased when enflurane is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when halothane is combined with ILOPROST.


The risk or severity of adverse effects can be increased when quetiapine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with azelastine.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Tramadol.


The risk or severity of adverse effects can be increased when estazolam is combined with scopolamine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when pramipexole is combined with Rotigotine.


The risk or severity of adverse effects can be increased when ondansetron is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Ramelteon.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with metyrapone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Mometasone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Ibrutinib.


The risk or severity of adverse effects can be increased when metronidazole is combined with Lopinavir.


The risk or severity of adverse effects can be increased when pancuronium is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when betaxolol is combined with enalapril.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Retigabine.


The risk or severity of adverse effects can be increased when quinidine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when butabarbital is combined with quetiapine.


The risk or severity of adverse effects can be increased when metoprolol is combined with spironolactone.


The risk or severity of adverse effects can be increased when Perospirone is combined with butamben.


The risk or severity of adverse effects can be increased when alprazolam is combined with dyclonine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when oxazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when pargyline is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with tiapride.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with epirizole.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with sevoflurane.


The risk or severity of adverse effects can be increased when desipramine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when felodipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when desipramine is combined with Vilanterol.


The risk or severity of adverse effects can be increased when enflurane is combined with felbamate.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with DEXKETOPROFEN.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Torasemide.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when secobarbital is combined with Flupentixol.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with indapamide.


The risk or severity of adverse effects can be increased when ketorolac is combined with suprofen.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Melatonin is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Tramadol is combined with chlormezanone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Tramadol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with propranolol.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with prazepam.


The risk or severity of adverse effects can be increased when prazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Salsalate.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when halothane is combined with minoxidil.


The risk or severity of adverse effects can be increased when halothane is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when ketamine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with pimozide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with citalopram.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Agomelatine is combined with maprotiline.


The risk or severity of adverse effects can be increased when cilnidipine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Apremilast is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when nicergoline is combined with ambroxol.


The risk or severity of adverse effects can be increased when prazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when dicumarol is combined with Nintedanib.


The risk or severity of adverse effects can be increased when captopril is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when etodolac is combined with DESONIDE.


The risk or severity of adverse effects can be increased when duloxetine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Milnacipran is combined with quetiapine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with mepivacaine.


The risk or severity of adverse effects can be increased when captopril is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with aspirin.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with bezafibrate.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Apremilast.


The risk or severity of adverse effects can be increased when cocaine is combined with benzocaine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when lisinopril is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when cocaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Toloxatone is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when Difenoxin is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Pipamperone.


The risk or severity of adverse effects can be increased when clonidine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with fludiazepam.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when trazodone is combined with scopolamine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with thalidomide.


The risk or severity of adverse effects can be increased when tacrolimus is combined with carmustine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with amoxapine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with nortriptyline.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when biperiden is combined with Mirabegron.


The risk or severity of adverse effects can be increased when carprofen is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with spironolactone.


The risk or severity of adverse effects can be increased when procaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when cabergoline is combined with topotecan.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with zotepine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with nortriptyline.


The risk or severity of adverse effects can be increased when metoclopramide is combined with amoxapine.


The risk or severity of adverse effects can be increased when thiothixene is combined with doxepin.


The risk or severity of adverse effects can be increased when Efonidipine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Tramadol is combined with buspirone.


The risk or severity of adverse effects can be increased when suprofen is combined with paramethasone.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with efavirenz.


The risk or severity of adverse effects can be increased when Tramadol is combined with oxycodone.


The risk or severity of adverse effects can be increased when lidocaine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Olmesartan is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when oxybutynin is combined with Mirabegron.


The risk or severity of adverse effects can be increased when meperidine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when phenytoin is combined with paroxetine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Tramadol.


The risk or severity of adverse effects can be increased when biperiden is combined with nalbuphine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Tixocortol.


The risk or severity of adverse effects can be increased when trandolapril is combined with sulindac.


The risk or severity of adverse effects can be increased when lorazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with venlafaxine.


The risk or severity of adverse effects can be increased when meperidine is combined with zopiclone.


The risk or severity of adverse effects can be increased when thioridazine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when imipramine is combined with nicardipine.


The risk or severity of adverse effects can be increased when amobarbital is combined with tizanidine.


The risk or severity of adverse effects can be increased when rasagiline is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when terbinafine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when lorazepam is combined with midazolam.


The risk or severity of adverse effects can be increased when mepivacaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when mepivacaine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when clemastine is combined with cetirizine.


The risk or severity of adverse effects can be increased when cilazapril is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when cabergoline is combined with prednisone.


The risk or severity of adverse effects can be increased when Pentolinium is combined with pancuronium.


The risk or severity of adverse effects can be increased when thioridazine is combined with ethotoin.


The risk or severity of adverse effects can be increased when naratriptan is combined with Tapentadol.


The risk or severity of adverse effects can be increased when epirizole is combined with betamethasone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when calcium lactate is combined with ergocalciferol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when sumatriptan is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when methadone is combined with efavirenz.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when LISURIDE is combined with loratadine.


The risk or severity of adverse effects can be increased when scopolamine is combined with felbamate.


The risk or severity of adverse effects can be increased when polythiazide is combined with deslanoside.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with ketoprofen.


The risk or severity of adverse effects can be increased when sulfisoxazole is combined with oxycodone.


The risk or severity of adverse effects can be increased when nicergoline is combined with Linagliptin.


The risk or severity of adverse effects can be increased when imipramine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when Linagliptin is combined with meperidine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with amcinonide.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when nisoldipine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when Rotigotine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when azelastine is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when metaraminol is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when methyldopa is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with etizolam.


The risk or severity of adverse effects can be increased when clomipramine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Olmesartan is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with fenbufen.


The risk or severity of adverse effects can be increased when docetaxel is combined with Clofarabine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with lisinopril.


The risk or severity of adverse effects can be increased when Talniflumate is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with amcinonide.


The risk or severity of adverse effects can be increased when oxprenolol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with metaproterenol.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with nefazodone.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with Pregabalin.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with vincristine.


The risk or severity of adverse effects can be increased when thiopental is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with azelaic acid.


The risk or severity of adverse effects can be increased when Clofarabine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when clorazepate is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with HEROIN.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Asenapine.


The risk or severity of adverse effects can be increased when olanzapine is combined with doxepin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Etidocaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Etidocaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Niraparib.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with glutethimide.


The risk or severity of adverse effects can be increased when butorphanol is combined with bromazepam.


The risk or severity of adverse effects can be increased when enalapril is combined with Salsalate.


The risk or severity of adverse effects can be increased when procyclidine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when brimonidine is combined with bumetanide.


The risk or severity of adverse effects can be increased when reserpine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when brimonidine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with paroxetine.


The risk or severity of adverse effects can be increased when enalapril is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when pentazocine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when nefazodone is combined with oxycodone.


The risk or severity of adverse effects can be increased when cocaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when cocaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when pentazocine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when trimetrexate is combined with xylometazoline.


The risk or severity of adverse effects can be increased when procarbazine is combined with droperidol.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with propranolol.


The risk or severity of adverse effects can be increased when clonidine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with clonidine.


The risk or severity of adverse effects can be increased when methadone is combined with thiamylal.


The risk or severity of adverse effects can be increased when sulpiride is combined with vigabatrin.


The risk or severity of adverse effects can be increased when bepridil is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when sulpiride is combined with benzocaine.


The risk or severity of adverse effects can be increased when Melatonin is combined with chlormezanone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when oxycodone is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Talniflumate is combined with acemetacin.


The risk or severity of adverse effects can be increased when lithium ion is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Melatonin is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Melatonin is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when trazodone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when resveratrol is combined with diflunisal.


The risk or severity of adverse effects can be increased when cilnidipine is combined with lovastatin.


The risk or severity of adverse effects can be increased when Nabilone is combined with timolol.


The risk or severity of adverse effects can be increased when oxycodone is combined with proparacaine.


The risk or severity of adverse effects can be increased when nimesulide is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with amisulpride.


The risk or severity of adverse effects can be increased when docetaxel is combined with Besifloxacin.


The risk or severity of adverse effects can be increased when loratadine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Pipamperone is combined with protriptyline.


The risk or severity of adverse effects can be increased when Pipamperone is combined with diltiazem.


The risk or severity of adverse effects can be increased when Pipamperone is combined with cetirizine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with flunarizine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with MELPERONE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with zotepine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with sertraline.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with azelastine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with propoxyphene.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when butorphanol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when irbesartan is combined with sulindac.


The risk or severity of adverse effects can be increased when formestane is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with triprolidine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with procaine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with promazine.


The risk or severity of adverse effects can be increased when paroxetine is combined with periciazine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when manidipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when diazepam is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when pentazocine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Pipamperone is combined with furosemide.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Pipamperone is combined with tizanidine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Articaine.


The risk or severity of adverse effects can be increased when clidinium is combined with flunarizine.


The risk or severity of adverse effects can be increased when Levoleucovorin is combined with 5-Fluorouracil.


The risk or severity of adverse effects can be increased when trandolapril is combined with Propacetamol.


The risk or severity of adverse effects can be increased when minoxidil is combined with irbesartan.


The risk or severity of adverse effects can be increased when butorphanol is combined with phenobarbital.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when benzocaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when methysergide is combined with oxymetholone.


The risk or severity of adverse effects can be increased when ketamine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when aspirin is combined with betamethasone.


The risk or severity of adverse effects can be increased when trazodone is combined with clonidine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when resveratrol is combined with alclometasone.


The risk or severity of adverse effects can be increased when thalidomide is combined with isradipine.


The risk or severity of adverse effects can be increased when Telithromycin is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when resveratrol is combined with mesalamine.


The risk or severity of adverse effects can be increased when ethotoin is combined with Olopatadine.


The risk or severity of adverse effects can be increased when thalidomide is combined with Olmesartan.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when betaxolol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when diazepam is combined with bromazepam.


The risk or severity of adverse effects can be increased when medrysone is combined with edrophonium.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with loteprednol.


The risk or severity of adverse effects can be increased when losartan is combined with trandolapril.


The risk or severity of adverse effects can be increased when reserpine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when loratadine is combined with clonazepam.


The risk or severity of adverse effects can be increased when sulindac is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when fosinopril is combined with nadolol.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when haloperidol is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when phenytoin is combined with maprotiline.


The risk or severity of adverse effects can be increased when bromocriptine is combined with vinorelbine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with apraclonidine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with flunarizine.


The risk or severity of adverse effects can be increased when rapamycin is combined with eperisone.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with sotalol.


The risk or severity of adverse effects can be increased when nitric oxide is combined with hydralazine.


The risk or severity of adverse effects can be increased when ketorolac is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when Telmisartan is combined with tiaprofenic acid.